Answers are grounded in this paper and cite their sources.
Asthma is an inflammatory disease characterized by reversible airflow limitation and hyperresponsiveness Inhaled corticosteroids (ICS) are considered the mainstay of asthma treatment Their role in the treatment of asthma has been reviewed recently Since the introduction of beclomethasone more than 25 yrs ago, new topical corticosteroids such as triamcinolone, flunisolide, budesonide and fluticasone have been introduced. Also, the patent on beclomethasone has expired in many countries, making the introduction of generic preparations possible. New modes of delivery of drugs have been developed, including different types of powder devices and spacers. New propellants, such as hydrofluoroalkanes (HFA), should shortly replace chlorofluorocarbons (CFC), eliminated for environmental reasons Clinical efficacy may be assumed from pharmacological equivalence, but for therapeutic equivalence and systemic effects, it should, ideally, be demonstrated
No takes yet. Share an insight, caveat, or question.
Boulet et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: